loratadine has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.
Excerpt | Relevance | Reference |
---|---|---|
"A 91-year-old man was diagnosed with ocular myasthenia gravis." | 1.46 | Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case. ( Clarke, DE; Hodgson, T; Singh, G, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Singh, G | 1 |
Hodgson, T | 1 |
Clarke, DE | 1 |
1 other study available for loratadine and Anti-MuSK Myasthenia Gravis
Article | Year |
---|---|
Leukocytoclastic Vasculitis Secondary to Pyridostigmine (Mestinon): Report of a Possible First Case.
Topics: Aged, 80 and over; Cholinesterase Inhibitors; Humans; Loratadine; Male; Myasthenia Gravis; Pyridosti | 2017 |